In HIV, the chronic inflammation which arises is not a

New Post Public Reply Private Reply Replies (1) Message Board
ohm20 MGK_2 #139760
607
Quote:
In HIV, the chronic inflammation which arises is not a result of an overactive immune state.


Chronic inflammation is always caused by an overactive immune system. In HIV patients on ART there are three main causes. Damage to intestinal walls during the active phase of HIV. Persistent HIV virus due to HIV virus reservoirs. As you mention other diseases can arise during the HIV active phase and even those that existed prior.

A wide array of inflammatory factors that leronlimab can control are elevated in PLWH individuals. There is also an imbalanced CD4/CD8 cell count in those with chronic inflammation which is usually typified by a low CD4 count along with a high CD8 count. As shown by Dr. Sacha the use of leronlimab can increase CD4 cell counts in patients with HIV. Patterson's work show's leronlimab can address the CD4/CD8 imbalance. CCR5 also helps differentiate CD8 T-cells into types. We know leronlimab pushes a TH1 cell differentiation which is pro-inflammatory but then knocks down the specific inflammatory factors. That may explain the immunomodulatory rather than immunosuppressive effect. It's probably something I should dig into but I don't know whether I want to go down another rabbit hole for a year.

Quote:
"So a vaccine, a cold, a herpes outbreak, clinical or subclinical, any sort of illness can turn the virus back on." He says, "blipping occurs with any immune activation event" and that is very bad because the person becomes infectious again."


Those blips while using leronlimab may have two causes. The other infection may cause a rapid rise in CCR5 that leronlimab does not cover in time and/or it causes HIV viral reservoirs to release their stores of HIV virus. If it's the first, leronlimab will eventually occupy all CCR5 again and stop further reproduction. If it's the second, then that released virus will have no CCR5 open with which to reproduce. Either way it would explain why the virus goes back down with continued use of leronlimab.

Quote:
"Inflammation shows that immune system components are not present and in place or are being depleted because they are actively dealing with some infectious agents. AIDS doesn't kill you - a deficient immune system kills you. AIDS means you will have Chronic Immune Activation Inflammation that will result in clots, strokes, heart attacks, liver and kidney failure, gut diseases, etc.

CD4+ and CD8+ cells are especially important to restore to homeostasis. HIV directly destroys CD4+ cells through the CCR5 receptor and CD8+ cells are depleted to exhaustion by RANTES. They work together in a certain ratio/balance. Restoring that balance is one of the most important things that LL does. I don't think inflammation can be stopped without that balance."


This references an active HIV infection. Under ART treatment you can see a low CD4 count along with a high CD8 count. Some will have a very good CD4 count along with a high CD8 count which will show more of a balance but it's still in an overreactive immune state. You want to see a normal state for both in relation to any current infections.

Quote:
Inflammation occurs as a result of the immune system components being either continuously depleted (as in the case of HIV/AIDS) or continuously consumed in fighting off other targets or unnecessary targets (AutoImmune Disease).


In active HIV expression and less so in chronic inflammation you will see older T cells with an overexpression of CD57. CD57 slows down the replication of T cells but not the creation of new ones thus the exhaustion. Interestingly PD-1 expression and TGF-b are associated with T-cell exhaustion and leronlimab downregulates both.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 31

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 29

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 18

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 26

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 25

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 28

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 18

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Action Initiated for Investors of Telix Pharmaceuticals Ltd.

Updated Category News Views 95

Class Action Lawsuit for Telix Pharmaceuticals Ltd. Investors Levi & Korsinsky, LLP has initiated a notification for investors in Telix Pharmaceuticals Ltd. The class action lawsuit aims to provide compensation for investors who have suffered losses. This action pertains to allegations of securities fraud impacting the company's reputation and financial integrity....

Continue Reading
Parcel Perform Elevates E-commerce Delivery with AI Decision Intelligence

Updated Category News Views 199

Revolutionizing E-commerce Delivery with AI In today’s landscape, AI is significantly altering the way consumers engage with e-commerce. Parcel Perform is at the forefront of this shift, urging businesses to 'Think Bigger on AI.' With Artificial Intelligence redefining the customer journey, a superior delivery experience has become paramount for success in online...

Continue Reading
Exploring New Innovations and Trends in China's Development

Updated Category News Views 321

Emerging Terms and Innovation from China's Latest Sessions In recent discussions, many revolutionary buzzwords have captured attention, signaling China’s aspirations for progress. New phrases like "funds and resources used to serve the people," "embodied AI," and "gazelle companies" reflect the ongoing transformation in sectors spanning government finance, technology,...

Continue Reading
Digital Realty Welcomes Paula Cogan as New EMEA Director

Updated Category News Views 265

Digital Realty Appoints Paula Cogan as Managing Director Digital Realty (NYSE: DLR), a leading global provider specializing in cloud- and carrier-neutral data center solutions, has announced the appointment of Paula Cogan as Managing Director and Head of the EMEA region. This strategic move is set to amplify Digital Realty’s growth in this essential market segment....

Continue Reading
Investors Urged to Act Before Deadline in DXC Class Action

Updated Category News Views 41

DXC Technology got hit with a class action lawsuit back in 2024 that sent ripples through the investor community. The Law Offices of Frank R. Cruz put out the call, reminding shareholders about an impending deadline to file a lead plaintiff motion. You buying DXC during the specified dates? You might wanna pay attention—this ain't just another legal shuffle. Financial...

Continue Reading